参考文献/References:
[1]Steinman RM,Cohn ZA.Identification of a novel cell type in peripheral lymphoid organs of mice.II.Functional properties in vitro[J].J Exp Med,1974,139(2):380-397.[2]Steinman RM,Lustig DS,Cohn ZA.Identification of a novel cell type in peripheral lymphoid organs of mice.3.Functional properties in vivo[J].J Exp Med,1974,139(6):1431-1445.[3]Liu YJ.Dendritic cell subsets and lineages,and their functions in innate and adaptive immunity[J].Cell,2001,106(3):259-262.[4]Blander JM.Regulation of the Cell Biology of Antigen Cross-Presentation[J].Annu Rev Immunol,2018,36:717-753.[5]Alloatti A,Kotsias F,Magalhaes JG,et al.Dendritic cell maturation and cross-presentation: timing matters![J].Immunol Rev,2016,272(1):97-108.[6]Giridharan S,Srinivasan M.Mechanisms of NF-kappaB p65 and strategies for therapeutic manipulation[J].J Inflamm Res,2018,11:407-419.[7]Wang Y,Song M,Zhou P,et al.TNFAIP3-upregulated RIP3 exacerbates acute pancreatitis via activating NLRP3 inflammasome[J].Int Immunopharmacol,2021,100:108067.[8]Zhou J,Hu M,He M,et al.TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury[J].Hepatology,2021,74(4):2133-2153.[9]Deng HJ,Deji Q,Zhaba W,et al.A20 Establishes Negative Feedback With TRAF6/NF-kappaB and Attenuates Early Brain Injury After Experimental Subarachnoid Hemorrhage[J].Front Immunol,2021,12:623256.[10]Ciccacci C,Latini A,Perricone C,et al.TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus,Rheumatoid Arthritis,and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients[J].J Immunol Res,2019,2019:6728694.[11]Sun L,Zou LX,Han YC,et al.A20 overexpression exerts protective effects on podocyte injury in lupus nephritis by downregulating UCH-L1[J].J Cell Physiol,2019,234(9):16191-16204.[12]Ochando J,Ordikhani F,Jordan S,et al.Tolerogenic dendritic cells in organ transplantation[J].Transpl Int,2020,33(2):113-127.[13]Hubert M,Gobbini E,Couillault C,et al.IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer[J].Sci Immunol,2020,5(46):eaav3942.[14]Bobryshev YV.Dendritic cells in atherosclerosis: current status of the problem and clinical relevance[J].Eur Heart J,2005,26(17):1700-1704.[15]Song X,Zhang H,Zhao Y,et al.HMGB1 Activates Myeloid Dendritic Cells by Up-Regulating mTOR Pathway in Systemic Lupus Erythematosus[J].Front Med (Lausanne),2021,8:636188.[16]Jia P,Pan T,Xu S,et al.Depletion of miR-21 in dendritic cells aggravates renal ischemia-reperfusion injury[J].FASEB J,2020,34(9):11729-11740.[17]Johnson DJ,Ohashi PS.Molecular programming of steady-state dendritic cells: impact on autoimmunity and tumor immune surveillance[J].Ann N Y Acad Sci,2013,1284:46-51.[18]Javan MR,Rahimpour A,Moazzeni SM.Simultaneous transduction of dendritic cells with A20 and BTLA genes stimulates the development of stable and efficient tolerogenic dendritic cells and induces regulatory T cells[J].Int Immunopharmacol,2021,99:107966.[19]Duy PN,Thuy NT,Trang BK,et al.Regulation of NF-kappa B- and STAT1-mediated plasmacytoid dendritic cell functions by A20[J].PLoS One,2019,14(9):e0222697.